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Numerous studies have demonstrated that cholesterol-rich membrane rafts play critical roles in multiple cellular functions.
However, the impact of the lipoproteins on the structure, integrity and cholesterol composition of these domains is not well
understood. This paper focuses on oxidized low-density lipoproteins (oxLDLs) that are strongly implicated in the development of
thecardiovasculardiseaseandwhoseimpactonmembranecholesterolandonmembraneraftshasbeenhighlycontroversial.More
speciﬁcally, we discuss three major criteria for the impact of oxLDL on membrane rafts: distribution of diﬀerent membrane raft
markers, changes in membrane cholesterol composition, and changes in lipid packing of diﬀerent membrane domains. We also
propose a model to reconcile the controversy regarding the relationship between oxLDL, membrane cholesterol, and the integrity
of cholesterol-rich membrane domains.
1.Introduction
Oxidative modiﬁcations of LDL (oxLDL) are considered
to be one of the major risk factors for the development
of coronary artery disease (CAD) and plaque formation
(reviewed in [1, 2]). Indeed, elevated levels of oxLDL are
associated with an increased risk of CAD [3–5]a n dc o r r e l a t e
withplasmahypercholesterolemiabothinhumans[6,7]and
in the animal models of atherosclerosis [8, 9]. It is also well-
known that exposure to oxLDL induces an array of proin-
ﬂammatory and proatherogenic eﬀects but the mechanisms
that underlie oxLDL-induced eﬀects remain controversial.
The prevailing hypothesis is that oxLDL results in loading
cells with cholesterol inducing formation of cholesterol-
laden macrophages (foam cells) and dysfunctional endothe-
lial cells. However, growing number of studies have shown
recently that the eﬀects of oxLDL on membrane cholesterol
homeostasis are complex and may actually involve choles-
terol depletion and disruption of cholesterol-rich membrane
domains (membrane rafts) rather than cholesterol loading.
Membrane rafts were originally described as cholesterol-
and sphingolipid-rich microdomains that provide plat-
forms for protein-protein interactions in multiple signaling
cascades [10–12]. A consensus deﬁnition for membrane
rafts was suggested at the Keystone Symposium on Lipid
Rafts and Cell Function (March 23–28, 2006 in Steamboat
Springs, CO): “Membrane rafts are small (10–200nm),
heterogeneous, highly dynamic, sterol- and sphingolipid-
enriched domains that compartmentalize cellular processes”
[13]. Most recently, Simons and Gerl [11] further deﬁned
membraneraftsas“dynamic,nonoscale,sterol-sphingolipid-
enriched, ordered assembles of proteins and lipids” that are
regulated by speciﬁc lipid-lipid, protein-lipid, and protein-
protein interactions [11]. The goal of this paper is to discuss
the recent advances in our understanding of the impact of
oxLDL on membrane rafts.
2. oxLDL: Deﬁnitions andComposition
The term oxidized LDL is used to describe LDL preparations
which have been oxidatively modiﬁed ex vivo under deﬁned
conditions, or isolated from biological sources. The most
typical procedure of LDL oxidation ex vivo is incubation of
LDL with metal ions, Cu2+ in particular, that leads to the
generationofmultiple oxidized productsin theLDLparticle,
including oxysterols, oxidized phospholipids, and modiﬁed
apolipoprotein B (reviewed in [14, 15]). The oxidized
LDL preparations described in the literature are broadly2 Journal of Lipids
divided into two main categories: “minimally modiﬁed LDL”
(MM-LDL) and (fully or extensively) oxidized LDL (oxLDL)
based on the degree of LDL oxidation. Cu2+ oxidation
of LDL can generate both minimally modiﬁed and fully
oxidized LDLs depending on the duration of the exposure
and ion concentration. Two other procedures that are also
used to generate oxLDL ex vivo are enzymatic oxidation
by 15-lypoxygenase or myeloperoxidase or by incubating
LDL with 15-lypoxygenase expressing cells (e.g., [16–19]). It
is important to note that while it is controversial whether
Cu2+ oxidation occurs in vivo, it was shown that there
are signiﬁcant similarities between Cu2+ oxidized LDL and
oxLDL found in atherosclerotic lesions [20]. Most of the
studies that examined the impact of oxLDL on membrane
rafts were performed using Cu2+-oxidized LDL.
3.oxLDLandDisruptionofCaveolae
Caveolae are well known to be a morphologically distinct
subpopulation of membrane rafts that contain multiple
signaling complexes and play major roles in the regulation of
cell signaling [26–28]. The ﬁrst clue that oxLDL may disrupt
caveolae structure came from a study of Smart et al. [29]
showing that cholesterol oxidation results in translocation
of caveolin from plasma membrane to Golgi. In this study,
ﬁbroblasts were exposed to cholesterol oxidase, an enzyme
that converts cholesterol to cholestenone [30] and while
cholestenone remained on the plasma membrane, this treat-
ment resulted in the majority of caveolin (∼60%) moving
from the plasma membrane to Golgi [29]. Internalization
of caveolin, in turn, was associated with a modest (10%)
decrease in the number of caveolae [29]. Since it was shown
in later studies that cells that are fully devoid of caveolin
do not form caveolae [31, 32], a relatively minor eﬀect
induced by a partial loss of caveolin suggests that it is present
in excess. Smart et al. suggested that the loss of caveolin
due to oxidative modiﬁcations of cholesterol may be one
of the mechanisms by which oxLDL disrupts endothelial
function.
A more direct evidence for oxLDL-induced disruption
of caveolae came from a later study of the same group [21]
demonstrating that a short (30min) exposure of porcine
aortic endothelial cells to a relatively low dose (10μg/mL)
of oxLDL results in internalization of caveolin (Figure 1)
and a dramatic, virtually total decrease of cholesterol level
in the caveolae fractions of these cells. Both the level and
the degree of LDL oxidation (15–20nmol/mg TBARS) used
in this study were comparable with those found in vivo
(7–35μg/mL, 11nmol/mg protein TBAR) [3, 20]. Since both
the structure and the function of caveolae critically depend
on membrane cholesterol [33, 34], Blair et al. [21]c o n c l u d e d
that oxLDL disrupts endothelial caveolae. Consistent with
this conclusion, it was also shown that cholesterol depletion
of caveolae resulted in internalization and inhibition of
endothelial nitric oxide (NO) synthase (eNOS), a key
enzyme, that is, regulated by caveolin and is responsible for
endothelial NO synthesis [21]. Blair et al. [21] also showed
that similar eﬀects on eNOS were observed in response to
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Figure 1: Oxidized LDL induces translocation of caveolin from
the plasma membrane to intracellular compartments. Endothelial
cells were treated with 10μg/mL of nonmodiﬁed LDL (nLDL) or
oxLDL (15–20nmol/mg TBARS) in 100% lipoprotein-deﬃcient
serum containing 20mm HEPES (pH 7.4) for 1h at 37◦C. Caveolin
was visualized with a rhodamine isothiocyanate-goat antirabbit
IgG. Adapted from [21].
cholesterol depletion supporting the notion that oxLDL-
induced eNOS inhibition is related to cholesterol depletion.
Consistent with these observations, a later study from the
same group [35] showed that the level of caveolae cholesterol
in oxLDL-treated endothelial cells can be preserved by
exposing the cells to high-density lipoproteins (HDL), which
in this case was suggested to serve as cholesterol donor and
r e s t o r ee N O Sf u n c t i o n .T h e s eo b s e r v a t i o n sl e dt oah y p o t h -
esis that oxLDL may actually act as a cholesterol acceptor
and remove cholesterol from the cellular membranes rather
than load cells with cholesterol. It is not clear, however,
how exactly oxLDL becomes a cholesterol acceptor. One
theoretical possibility would be a direct exchange of lipids
between the plasma membrane and the lipid core of the
oxLDL particle. However, Uittenbogaard et al. [35] showed
that oxLDL-induced depletion of endothelial caveolae and
internalization of eNOS is mediated by the CD36 receptor,
one of the major scavenger receptors that are responsible for
the recognition and internalization of oxLDL, a pathway that
leadstooxLDLdegradation[36,37],adetaileddescriptionof
diﬀerent oxLDL receptors is presented in our recent review
and is beyond the scope of the current discussion [38]. An
involvement of a scavenger receptor suggests that oxLDL
needs to be internalized and possibly degraded to induce
cholesterol depletion of caveolae. An alternative possibility
would be that oxLDL binding to the CD36 receptors
activates a signaling pathway that leads to cholesterol eﬄux.Journal of Lipids 3
Control oxLDL MβCD
Figure 2: oxLDL indices internalization of GM1. Typical images of ﬂuorescently labeled CTx staining in nonpermeabilized control, oxLDL-,
and MβCD-treated bovine aortic endothelial cells showing the surface expression of GM1 on the plasma membrane. Similar to the earlier
studies, cells were exposed to 10μg/mL oxLDL for 1h at 37◦C but the degree of LDL oxidation was a little lower (10–15nmol/mg TBARS).
For cholesterol depletion, cells were treated with 5mM MβCD for 1 hour, a treatment that typically decreases cellular cholesterol level by
50%. Adapted from [22].
Thesemechanisms, however, areentirely not understood yet.
Recently, we have shown that oxLDL results in ﬂuidization
of cholesterol-rich membrane domains and suggested that
it might be attributed to a redistribution of cholesterol
betweencholesterol-richandcholesterol-poordomains[25],
a new paradigm for oxLDL-induced impact on membrane
cholesterol. This possibility will be discussed in detail in the
last part of this paper.
Another important clue about the mechanism that
may underlie oxLDL-induced cholesterol depletion comes
from the studies that focus on oxidized phospholipids.
The ﬁrst detectable products of LDL lipid oxidation are
oxidized polyunsaturated fatty acids and the products of
the oxidation, particularly oxidized products of palmitoyl-
arachidonyl-phosphatidyl choline (oxPAPC), constitute one
of the major active components of minimally oxidized LDL
[39, 40]. Furthermore, oxPAPC were identiﬁed as the lipid
moieties critical for the recognition of oxLDL by CD36
receptors [41]. Similar to oxLDL, oxPAPC also induced
internalization of caveolin and depletion of cholesterol
from caveolin-rich membrane fractions [39, 42]. These
observations further underscored the role of CD36 receptors
in the observed eﬀects.
Interestingly, the authors [43] have shown that diet-
induced hypercholesterolemia in apoE-deﬁcient mice
(apoE−/−), a mouse model for atherosclerosis, also results
in a dramatic decrease of the cholesterol level in caveolae
isolated from whole blood vessels. Furthermore, since endo-
thelial cells constitute only a single cell layer on the inner
surface of the blood vessels while the majority of the vessel
cells are contributed by smooth muscle cells, a decrease
in the level of caveolae cholesterol in the whole vessel
homogenate indicates that this eﬀect is observed not only in
endothelial cells but also in the smooth muscle cells. This
study demonstrates that depletion of caveolae cholesterol
may occur both in vitro and in vivo. More studies, however,
are needed to evaluate the impact of oxLDL on caveolae on
the structural level and to elucidate the mechanisms that
underlie these eﬀects.
4. oxLDLand Disruptionof Noncaveolae
Cholesterol-Rich Membrane Rafts
It is also well recognized today that cholesterol-rich mem-
brane domains may form in the absence of caveolin indicat-
ing the existence of noncaveolae membrane rafts [28, 44].
The exact nature, morphology, size, density, and molecular
composition of noncaveolae rafts in cellular membranes
are still controversial, as summarized in multiple excellent
reviews (e.g., [13, 45–48]) and a detailed discussion of these
topics is beyond the scope of the current review. These
noncaveolae membrane rafts are typically identiﬁed either
by clustering of the proteins that are anchored to glyco-
sylphosphatidylinositol (GPI-anchored proteins) [23, 49]o r
by ganglioside GM1, another major membrane raft marker
[50]. Indeed, it was shown that while GPI-anchored proteins
partition into detergent insoluble fractions that contain
cholesterol-rich membrane domains, they are diﬀusely dis-
tributed at the cell surface and do not colocalize with caveo-
lae except for after cross-linking [49, 51]. It is also important
to note that while caveolae are estimated to constitute only
about 2%–7% of the cell surface [34, 49], the surface area
occupied by cholesterol-rich membrane domains appears
to constitute a much larger area of the plasma membrane
surface, as estimated by tracking various membrane raft
markers. For example, tracing of single lipid molecules
showed that about 15% of the plasma membrane is occupied
by the regions of slow lipid motion that are expected to
correspond to the ordered cholesterol-rich membrane raft
domains [52]. Similar or even higher estimates (10%–40%)
were obtained in other studies using diﬀerent probes [25,
53–55]. It is generally believed, therefore, that noncaveolae
rafts constitute a signiﬁcant population of cholesterol-rich
ordered membrane domains.
Several studies have shown that exposure to oxLDL
results in signiﬁcant redistribution of noncaveolae mem-
brane raft markers. First, Zeng et al. [56] showed that expo-
sure of Chinese Hamster Ovary cells (CHO) that overexpress
CD36 receptors to oxLDL results in the internalization of4 Journal of Lipids
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Figure 3: Visualizing noncaveolae lipid rafts by proximal imaging of GPI-anchored tt-GFP. Human umbilical vein endothelial cells are
transfected with GPI-anchored temperature-tolerant green ﬂuorescent protein (ttGFP) probe and exposed either to cholesterol oxidase
( c h o lo x ,0 . 5U / l )f o r6 0m i n u t e so r2m Mm e t h y l - β-cyclodextrin (MβCD) for 30 minutes. Adapted from [23].
GPI-anchored decay accelerating factor (DAF), one of the
GPI-anchored proteins that was used earlier to analyze the
diﬀerential distributions of GPI-anchored proteins and cave-
olin[49].Surprisingly,eventhoughcaveolinisalsoexpressed
in CHO cells, in contrast to an earlier study in endothelial
cells [21], it was not internalized in response to oxLDL.
One possible explanation of this discrepancy is diﬀerential
partitioning of CD36 receptors into diﬀerent membrane
domainsinendothelialcellsandinCHOcells.Morerecently,
we have shown that exposure of endothelial cells to oxLDL
also induces internalization of GM1 and that the eﬀect of
oxLDL was fully simulated by exposing the cells to methyl-
β-cyclodextrin (MβCD), a cyclic oligosaccharide that binds
to cholesterol with high aﬃnity and depletes membrane
cholesterol (Figure 2,[ 57]). Taken together, these studies
suggest that oxLDL induces internalization of membrane
raft protein complexes from the plasma membrane to the
intracellular membranes. The similarity between the eﬀects
of oxLDL and cholesterol depletion on the distribution of
GM1 between the plasma and the intracellular membranes
supports the hypothesis that oxLDL disrupts cholesterol-rich
membrane domains.
Further insights into the impact of oxLDL on membrane
rafts was recently obtained using a novel methodology
called proximity imaging [23]. This approach is based
on a property of a temperature-tolerant mutant of Green
Fluorescent Protein (ttGFP) to undergo a shift in absorbance
as a function of the distance of the neighboring molecules
providing a unique tool to study molecule clustering [58].
Patschan et al. [23] used this approach to analyze the
distribution of GPI-anchored ttGFP, as a probe to visualize
membrane rafts in endothelial cells. As expected, exposing
the cells to cholesterol oxidase or to MβCD resulted in
signiﬁcant decrease of the ttGFP clusters on the membrane
(Figure 3). Furthermore, the same eﬀect was also observed
in cells exposed to cholesterol oxidase. It is a little surprising,
though, that in this study GPI-anchored ttGFP ﬂuorescence
occupied only less than 2% of the cell surface, a much lower
estimate that was obtained by other methods. An intriguing
possibility is that GPI-anchored proteins represent a small
speciﬁc subpopulation of membrane rafts. Alternatively, this
discrepancy may also be due to the eﬃciency of GPI-
ttGFP overexpression. In this study, oxLDL by itself did not
have a signiﬁcant eﬀect on the surface area of the rafts,
as estimated by clustering of the GPI-ttGFP but exposing
the cells to oxLDL in the presence of dimethyl-L-arginine
dihydrochloride (ADMA), an inhibitor of NO synthesis,
resulted in a signiﬁcant eﬀect even though ADMA by itself
also had no eﬀect [23]. These observations suggested that
oxLDL disrupts membrane rafts in a NO-dependent way
but the exact mechanism underlying these eﬀects is not
clear. Patschan et al. [23] proposed that oxLDL-induced
modiﬁcationsofthelipidcompositionofthemembraneplay
a key role in the disruption of GPI-ttGFP clustering. Thus,
multiplestudiesdemonstratethatoxLDLmayinducedisrup-
tionofmembranerafts,asestimatedbytheinternalizationor
unclustering of diﬀerent membrane raft markers.
5. oxLDL and Formation of
Ceramide Platforms
Several studies have shown that oxLDL also induces hydrol-
ysis of sphingomyelin (SM) (e.g., [59–63]), a second major
lipid component of membrane rafts (reviewed in [13,
64]). SM hydrolysis is expected to disrupt the integrity of
membrane rafts, alter cholesterol distribution between the
cellular membranes, and increase the level of membrane
ceramide, which by itself may form tightly packed ceramide-
rich microdomains (reviewed in [48, 64]). Indeed, multi-
ple studies have shown that oxLDL-induced hydrolysis of
sphingomyelin is accompanied with a concomitant increase
in the level of cellular ceramide [59–63]. Furthermore,
Grandl et al. [65] have recently shown that oxLDL results
in the formation of large ceramide-rich membrane rafts
in human macrophages that could be detected by ﬂu-
orescent microscopy. It is also important to note that
hydrolysis of sphingomyelin and an increase in the cellular
ceramide levels were implicated in several of oxLDL/oxPC-
dependent cellular processes, such as oxLDL-induced prolif-
eration of vascular smooth muscle cells [59] and apoptosis
of vascular endothelial cells [62]a n dm a c r o p h a g e s[ 60]Journal of Lipids 5
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Figure 4: oxLDL and cholesterol depletion have similar eﬀects on realignment of endothelial cells in the direction of the ﬂow. Left column:
typical images of control, oxLDL-treated cells (10μg/mL oxLDL, 1h), and MβCD-treated cells (5mM, 1h) exposed to 10dyn/cm2 for
12 hours. Right column: typical images of F-actin structure in the same cell populations. Arrow indicates the direction of ﬂow. Adapted
from [24].
and oxPC-induced synthesis of an inﬂammatory cytokine
interleukin-8 [66]. Speciﬁc pathways, however, involved in
the diverse ceramide-induced cellular eﬀects have been sum-
marized in a number of excellent reviews and are beyond the
scope of this review (e.g., [48, 67, 68]). An interesting ques-
tion is whether oxLDL-induced disruption of cholesterol-
rich membrane domains and formation of ceramide-rich
domains are mutually dependent. Indeed, since SM has high
aﬃnity for cholesterol, SM hydrolysis may be expected to
resultinapartiallossofcholesterolfromSM-richmembrane
domains.Consistentwiththisidea,SMhydrolysisinducedby
exposing cells to a bacterial enzyme Sphingomyelinase D was
shown to induce an increase in cholesterol internalization
and esteriﬁcation both in macrophages and in endothelial
cells[25,69].Sinceitisalsoknownthatcholesterolesteriﬁca-
tion requires its internalization from the plasma membrane
to the intracellular compartments, we tested a possibility
that oxLDL may induce cholesterol depletion of the plasma
membranecholesterol-richdomainsbyinducingitsinternal-
izationandesteriﬁcation.Ourobservations,however,didnot
supportthispossibilitybecauseatleastinendothelialcellswe
detected no measurable increase in cholesterol esteriﬁcation
inresponsetooxLDL[25].Also,asdescribedbelow,whilewe
found strong similarities between the eﬀects of oxLDL and
cholesterol depletion on endothelial biomechanical proper-
ties, eﬀects of SM hydrolysis were entirely diﬀerent [25].
More studies, however, are needed to elucidate possible links
between oxLDL, cholesterol, and SM in diﬀerent cell types.
6. oxLDLand Cholesterol Depletion
In spite of the mounting evidence that oxLDL may disrupt
theintegrityofcholesterol-richmembranerafts,asjudgedby
the redistribution of diﬀerent raft markers, direct evidence
for the ability of oxLDL to actually remove cholesterol
from the cellular membrane remains elusive and contro-
versial. Speciﬁcally, while some studies have demonstrated
oxLDL/oxPC-inducedcholesteroldepletion,mostlyfromthe
caveolae fraction of the plasma membrane [21, 42, 43], other
studies showed no signiﬁcant eﬀect [22, 25, 70] neither in
cholesterol-rich nor in cholesterol-poor membrane fractions
[22]. Most recently, we showed that oxLDL indeed slightly
facilitates cholesterol eﬄux from endothelial cells but the
general eﬀect is very mild and has no signiﬁcant impact on
the total level of cholesterol in the membrane [25]. Also, as
described above, we found no evidence that oxLDL induces6 Journal of Lipids
internalization ofcholesteroltotheintracellularmembranes,
as assayed by cholesterol esteriﬁcation [25]. However, while
direct evidence for oxLDL-induced cholesterol depletion is
very limited, a growing number of studies demonstrate
striking similarities between the eﬀects of oxLDL and of
cholesterol depletion on an array of diﬀerent cellular func-
tions,providingindirectindicationthattheimpactofoxLDL
on cellular functions is related to cholesterol depletion.
As described above, earlier studies by Blair et al.
[21] showed that oxLDL-induced inhibition of endothe-
lial nitric synthase (eNOS) can be simulated by MβCD-
induced cholesterol depletion and abrogated by maintain-
ing cellular cholesterol at a constant level [35]. Similarly,
oxPAPC-induced production of an inﬂammatory cytokine
Interleukin-8 was also simulated by MβCD-cholesterol
depletion and prevented by cholesterol loading [42]. Fur-
thermore, Yeh et al. [42] showed that oxPAPC also results in
a sustained activation of sterol regulatory element-binding
protein (SREBP) and induction of SRBEP-targeted genes
(LDLR and HMG CoA synthase). Since it is well known
that SREBPs are regulated by the level of cellular cholesterol
and activated by cholesterol depletion [71], the ability of
oxPAPC to activate SREBP is consistent with the observation
that oxPAPC induces cholesterol depletion. More recently,
our studies have shown that multiple eﬀects of oxLDL on
endothelial biomechanical properties can also be simulated
by cholesterol depletion. First, we have shown that exposure
tooxLDLanddepletionofmembranecholesterolresultinan
increase in endothelial stiﬀness, as estimated by measuring
progressive membrane deformation in response to negative
pressure [22, 72] or by atomic force microscopy [25]. The
same correlation was observed also for the ability of the
cells to generate force on the cell-substrate interface [22, 25],
to form endothelial networks in 3D collagen gels [22, 25]
and to realign in the direction of the ﬂow ([24], Figure 4).
Furthermore, the similarities between the eﬀects of oxLDL
and MβCD on endothelial realignment in the direction of
the ﬂow are apparent both on the level of single cells and
of individual F-actin ﬁbers ([24], Figure 4). A correlation
betweentheeﬀectsofoxLDLandcholesteroldepletionacross
an array of diﬀerent cellular functions suggests that there
is a common mechanistic denominator. However, it is also
possible that the common denominator is not cholesterol
depletion but rather a downstream step that can be activated
by both oxLDL and by cholesterol depletion independently.
To address this possibility, we tested whether the eﬀects of
oxLDL can be reversed by increasing the level of membrane
cholesterol. Indeed, our further studies have shown that
all of the eﬀects of oxLDL on endothelial biomechanical
properties could be reversed by supplying the cells with a
surplus of cholesterol either by sequential exposing the cells
to acLDL [24] or by sequentially exposure to oxLDL and
t h e nt oM βCD-cholesterol [25]. These observations indicate
that oxLDL-induced eﬀects on endothelial biomechanical
properties are cholesterol dependent. It is important to
note that enriching endothelial cells with cholesterol in the
absence of oxLDL had no eﬀect on endothelial biomechanics
[25, 72] indicating that the reversibility is not a result
of simple cancellation of the two opposite eﬀects. Thus,
multiple studies show a remarkable similarity between the
eﬀects of oxLDL and of MβCD on endothelial properties.
In contrast, we found no similarities between the eﬀects
on oxLDL and SM hydrolysis on endothelial biomechanics
suggesting that these eﬀects cannot be attributed to oxLDL-
induced formation of ceramide platforms [25].
Most surprisingly, no changes in cellular cholesterol were
observed in the same studies that showed that oxLDL-
induced eﬀects are simulated by cholesterol depletion and
reversed by cholesterol enrichment [22, 25]. To resolve this
discrepancy, we proposed a hypothesis that oxLDL may
alter the lateral distribution of membrane cholesterol, which
in turn may disrupt cholesterol-rich membrane domains
and induce cholesterol depletion-like physiological eﬀects.
This hypothesis was addressed in our recent study by
estimating lipid packing of cholesterol-rich and cholesterol-
poor membrane domains in cells exposed to oxLDL.
7. Impact of oxLDL on Lipid Packing of
Membrane Domains inLivingCells
Numerous studies have examined physical properties of cell
membranes under diﬀerent experimental conditions using
probes that are sensitive to membrane ﬂuidity/lipid packing.
However,untilrecentlytheseapproachesdidnotallowexam-
ining the heterogeneity of the biophysical properties of the
biological membranes in living cells. A major breakthrough
in alleviating this constraint was developing Laurdan two-
photon imaging, a novel approach to probe lipid order of
diﬀerent membrane domains in living cells [53, 73]. The
general principle of this technique is that Laurdan dye is
sensitive to the polarity of the local environment and under-
goes a red shift as the phase boundary of the lipid bilayer
changes from gel to ﬂuid [53,74].When using this approach,
cells typically present a punctuate distribution of membrane
domains that range in their biophysical properties from
ﬂuid to ordered, as estimated by general polarization (GP)
ratio that reﬂects lipid packing: the higher the GP value,
the more ordered is the domain [53, 73]. Furthermore,
the distribution of membrane domains between ﬂuid and
ordered can be analyzed quantitatively by analyzing the
distributions of the GP values for individual cells. More
speciﬁcally, the histograms of the GP values are typically
ﬁtted with a two-Gaussian distribution with the two peaks
representing ordered (peak with higher GP values) and
disordered (lower GP values) membrane domains [53, 73].
Earlier studies have shown that, as expected, cholesterol
depletion results in a signiﬁcant shift to less ordered
membrane structure, as indicated by a decrease in the GP
values corresponding to a decrease lipid packing [53, 74].
It is also important to note that MβCD-induced cholesterol
depletion results in a decrease in lipid packing/ﬂuidization
of both ordered and disordered domains, as apparent from
a decrease in the GP values for both types of the domains.
Surprisingly, the areas that are covered by the ordered and
ﬂuid domains do not change signiﬁcantly in cholesterol-
depleted cells suggesting that MβCD aﬀects the physical
properties of these domains rather than their coverage ofJournal of Lipids 7
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Figure 5: Impact of oxidized low-density lipoprotein (oxLDL) on lipid packing of membrane domains in bovine aortic endothelial cells.
(a) Typical general polarization (GP) images of control cells (Ctrl), MβCD-treated cells, oxLDL-treated cells (oxLDL), or cells exposed to
oxLDL and MβCD-cholesterol sequentially (oxLDLChol). Scale bar is 5.6μm. (b) zoom-in representative regions of the GP images shown
in (a) (the zoomed regions are 5.6μm×5.6μm). Scale bar is 1μm. (c) GP histograms for the four experimental cell populations (dots) ﬁtted
by a two-Gaussian distribution with the curve representing ordered domains (red) and the curve representing ﬂuid domains (green). The
sum of the Gaussians is shown in black. Adapted from [25].
the cell surface. Our recent observations are fully consistent
with these studies [25]. These observations also provided
furtherinsightsintotherelationshipbetweencholesteroland
diﬀerent membrane domains. Indeed, one of the common
misconceptions in the membrane raft ﬁeld is an assumption
that MβCD removes cholesterol speciﬁcally from the raft
domains and therefore interpreting the eﬀects of cholesterol
depletion as direct evidence for the involvement of mem-
brane rafts. In contrast, several studies have shown that care-
ful examination of the lipid composition of cholesterol-rich
and cholesterol-poor membrane domains demonstrates that
MβCD removes cholesterol from both types of the domains
(reviewed in [75]). This conclusion is further conﬁrmed by
Laurdan imaging demonstrating that, as described above,
both types of the domains become more ﬂuid. Conversely,
we have shown that cholesterol enrichment increases the
GP values in both ordered and ﬂuid membrane domains
suggesting that, as expected, the cholesterol enrichment
tightens lipid packing in both types of the domains [25].
Most importantly, employing Laurdan two-photon
imaging allowed us to obtain new insights into the impact
of oxLDL on the membrane structure of endothelial cells
[25]. Speciﬁcally, we have shown that, consistent with
the idea that oxLDL induces disruption and cholesterol
depletion of cholesterol-rich membrane domains, exposure
tooxLDLindeed resultedinashift tolessorderedmembrane
structure, particularly of the ordered domains (Figure 5).
Conversely, exposure of oxLDL-treated cells to MβCD-
cholesterol resulted in a partial reversal of its eﬀect on the
properties of the ordered domains. However, while there is8 Journal of Lipids
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Figure 6: A model proposed for the impact of oxLDL on the lateral
distribution of cholesterol between raft and nonraft domains.
again signiﬁcant similarity between the eﬀects of oxLDL and
cholesterol depletion, the two are not identical. The main
diﬀerence between oxLDL and MβCD is that oxLDL aﬀects
primarily the ordered domains with no signiﬁcant eﬀect on
theﬂuiddomainswhereasMβCD-inducedcholesteroldeple-
tionaﬀectsboth.Inaddition,whilecholesteroldepletionalso
results in the overall decrease of the general GP values that
reﬂect the packing of the entire membrane, oxLDL has no
eﬀect.AdecreaseingeneralGPvaluesincholesterol-depleted
cells is not surprising and is fully consistent with the overall
decrease in membrane cholesterol. The second observation
is more signiﬁcant suggesting that the total amount of
cholesterol in the membrane does not change signiﬁcantly.
This indeed is consistent with the lack of oxLDL eﬀect on
the level of membrane cholesterol as estimated by other
methods. We proposed, therefore, that oxLDL may disrupt
membrane rafts not by removing membrane cholesterol but
rather by incorporation of oxysterols into the membrane.
8. Impact of Oxysterolson Membrane Rafts
Oxysterols are found in abundance in Cu2+-oxidized LDL,
in which cholesterol is oxidized preferably at 7 posi-
tions resulting in the generation of 7-ketocholesterol, 7β-
hydroxycholesterol,and7α-hydroxycholesterol [76].Inaddi-
tion, 27-hydroxycholesterol, that is, generated in vivo, has
been shown to accumulate in foam cells in atherosclerotic
lesions [76]. Several studies have shown that oxysterols result
in inhibition of cholesterol eﬄux in the mouse and it was
suggested that impairment of cholesterol homeostasis by the
inhibition of cholesterol eﬄux may be mechanism by which
oxysterols aﬀect cellular function [77, 78]. Interestingly, 7-
ketocholesterol was shown to deplete cholesterol speciﬁcally
from the raft domains in human macrophages [79]a n d
disrupt lipid packing of the immunological synapses in
sterol-enriched T lymphocytes [80] and in cholesterol-
rich membrane domains in endothelial cells [25]. These
observations suggest that incorporation of oxysterols may
also play an important role in oxLDL-induced disruption of
cholesterol-rich membrane domains.
9. Conclusions
So, how can we reconcile the following observations: (i)
exposure to oxLDL results in internalization/dispersion
of membrane raft markers but has only small or no
eﬀect on the level of membrane cholesterol; (ii) multiple
eﬀects of oxLDL on cellular function can be simulated by
cholesterol depletion or direct exposure to 7-ketocholesterol
and reversed by cholesterol enrichment; (iii) exposure to
oxLDL induces a decrease in lipid packing, speciﬁcally in
cholesterol-rich ordered membrane domains? To reconcile
theseobservations,weproposeanewmodelfortheimpactof
oxLDL on membrane rafts (Figure 6). First of all, we propose
that oxLDL induces a lateral redistribution of cholesterol
between ordered domains and ﬂuid domains, which results
in a decrease in lipid packing of the ordered domains but
no signiﬁcant change in the more abundant ﬂuid domains.
We also propose that direct insertion of oxysterols into the
plasma membrane may contribute to this eﬀect. Clearly,
more studies are required to test this paradigm.
While elevated levels of oxLDL are associated with hy-
percholesterolemia and development of atherosclerosis, the
propensity of the evidence suggests that oxLDL results in
disruptionofcholesterol-richmembranedomainsandeither
depletion or lateral re-distribution of cholesterol between
the ordered and the ﬂuid domains of the membrane.
Furthermore, multiple oxLDL-induced changes in cellular
functions, particularly in endothelial cells, are apparently
related to the disruption of cholesterol-rich domains rather
than to cholesterol enrichment. These conclusions may have
a major impact on our understanding of the mechanisms of
oxLDL function and the role of membrane rafts in oxLDL-
induced pathological eﬀects.
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